Inter Pharma PCL (BKK:IP)

Inter Pharma PCL Revenue

Inter Pharma PCL had revenue of 557.41M THB in the quarter ending June 30, 2026, with 3.07% growth. This brings the company's total for the last twelve months to 2.26B, up 10.15% year-over-year. In the year 2025, Inter Pharma PCL had annual revenue of 2.21B with 15.80% growth. That makes Inter Pharma PCL the 25,747th largest company in the world by revenue and 414th in Thailand.

• Revenue (ttm): 2.26B
• Revenue Growth: +10.15%
• P/S Ratio: 1.29
• Revenue / Employee: n/a
• Employees: 64
• Market Cap: 2.95B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Human Healthcare 1.58B 71.3%
• Animal Healthcare 373.48M 16.9%
• Hospital and clinics 241.99M 10.9%
• Unallocated Other Income 20.57M 0.9%

Fiscal year ended Dec 31, 2025 See the full Inter Pharma PCL breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.21B	302.11M	15.80%
Dec 31, 2024	1.91B	113.17M	6.29%
Dec 31, 2023	1.80B	264.33M	17.23%
Dec 31, 2022	1.53B	613.46M	66.61%
Dec 31, 2021	920.98M	474.05M	106.07%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error